| Customization: | Available |
|---|---|
| CAS: | 93106-60-6 |
| Molecular Weight: | 359.40 |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Enrofloxacin This product is a broad-spectrum bactericidal drug with special effects on mycoplasma. It has bactericidal effect on Escherichia coli, Klebsiella, Salmonella, Proteus, Pseudomonas aeruginosa, Haemophilus, Pasteurella multocida, Pasteurella hemolytica, Staphylococcus aureus, Streptococcus, etc.
Enrofloxacin can be used as an animal drug. It has a long half-life in animals and good tissue distribution. It is a broad-spectrum bacteriostatic agent. It has bacteriostatic effect on Gram-positive bacteria, negative bacteria and mycoplasma. It is used in the control of vibrio and colibacillosis in farmed fish.
Enrofloxacin is a synthetic third-generation quinolone antibacterial drug, also known as ethyl ciprofloxacin, which was approved by the FDA on October 4, 1996. It is a quinolone antibacterial drug dedicated to livestock, poultry and aquatic products. It can combine with bacterial DNA gyrase subunit A, thereby inhibiting the cutting and connecting functions of the enzyme, preventing the replication of bacterial DNA, and showing antibacterial effect.
|
Foreign name Enrofloxacin Molecular formula C19H22FN3O3 Molecular weight 359.40 CAS number: 93106-60-6 Also known as ethyl ciprofloxacin Features Animal-specific drugs. |
){kind=link}